IL4 and neoplasm: Given that this tumor-inhibitory role could be compromised by antagonistic Th2 (IL13, IL4) and TGFB pathways [25,26], we hypothesized that tumours exhibiting simultaneous high Th1 and low TGFB activity may exhibit a better prognosis than tumors stratified by each pathway alone.